文献速递免疫规划传染病防控与疫情报告

含密码子优化A27L的质粒疫苗接种可降低痘苗病毒攻击后的病毒复制与播散

Vaccination with a codon-optimized A27L-containing plasmid decreases virus replication and dissemination after vaccinia virus challenge.
PubMed 文献 · Vaccine · 2017-06-16

天花由天花病毒(VARV)引起,尽管WHO于1980年宣布根除,但生物恐怖攻击风险上升。现有活痘苗病毒(VACV)疫苗ACAM2000对免疫受损或既往有皮肤疾病者可引起并发症,因此需开发更安全有效的疫苗。本研究评估编码密码子优化VACV A27L基因的pVAX1质粒(pA27LOPT)±咪喹莫特佐剂的免疫应答,小鼠接种两周后经鼻攻击VACV,pA27LOPT和pA27LOPT+咪喹莫特组肺和卵巢病毒滴度显著降低。

要点

  • pA27LOPT±咪喹莫特佐剂在接种后两周诱导针对A27L的保护性免疫应答。
  • VACV攻击后,pA27LOPT和pA27LOPT+咪喹莫特组小鼠肺和卵巢病毒滴度显著低于对照组。
  • 该无病毒DNA疫苗平台为开发更安全有效的天花疫苗提供了替代方向。

核心结论

  • 该无病毒DNA疫苗配方可降低病毒复制与播散,为更安全有效的疫苗提供了替代方向。

研究设计与样本

  • 研究评估pVAX1质粒编码密码子优化VACV A27L基因(pA27LOPT)±咪喹莫特佐剂的免疫应答,小鼠接种两周后经鼻攻击VACV。

主要发现

  • 所有检测中,基于A27的DNA疫苗均诱导保护性免疫应答。
  • 接种两周后经鼻攻击VACV,pA27LOPT和pA27LOPT+咪喹莫特组小鼠肺和卵巢病毒滴度显著低于对照组。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Smallpox is a disease caused by Variola virus (VARV). Although eradicated by WHO in 1980, the threat of using VARV on a bioterror attack has increased. The current smallpox vaccine ACAM2000, which consists of live vaccinia virus (VACV), causes complications in individuals with a compromised immune system or with previously reported skin diseases. Thus, a safer and efficacious vaccine needs to be developed. Previously, we reported that our virus-free DNA vaccine formulation, a pVAX1 plasmid encoding codon-optimized VACV A27L gene (pA27LOPT) with and without Imiquimod adjuvant, stimulates A27L-specific production of IFN-γ and increases humoral immunity 7days post-vaccination. Here, we investigated the immune response of our novel vaccine by measuring the frequency of splenocytes producing IFN-γ by ELISPOT, the TH1 and TH2 cytokine profiles, and humoral immune responses two weeks post-vaccination, when animals were challenged with VACV. In all assays, the A27-based DNA vaccine conferred protective immune responses. Specifically, two weeks after vaccination, mice were challenged intranasally with vaccinia virus, and viral titers in mouse lungs and ovaries were significantly lower in groups immunized with pA27LOPT and pA27LOPT+Imiquimod. These results demonstrate that our vaccine formulation decreases viral replication and dissemination in a virus-free DNA vaccine platform, and provides an alternative towards a safer an efficacious vaccine.

来源:Vaccine,查看原文。版权归原作者所有。

引用

  1. Martínez O, Bravo Cruz A, Santos S, et al. Vaccination with a codon-optimized A27L-containing plasmid decreases virus replication and dissemination after vaccinia virus challenge. Vaccine. 2017. PMID: 28629922. doi:10.1016/j.vaccine.2017.05.091

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。